1 Min Read
NEW YORK, Jan 15 (Reuters) - Santarus Inc : * Up 8.6 percent premarket after FDA OK’s its oral drug to treat a type of inflammatory bowel disease
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.